Eric Swayze Ionis Pharmaceuticals Inc (IONS) insider trading activity

IONS Quotes by TradingView

Eric Swayze is Officer Level 14 of IONIS PHARMACEUTICALS INC. Currently has a direct ownership of 34,929 shares of IONS, which is worth approximately $1.31 Million. The most recent transaction as insider was on Feb 29, 2024, when has been sold 605 shares (Common Stock) at a price of $34.42 per share, resulting in proceeds of $20,824. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34.9K
0% 3M change
7.42% 12M change
Total Value Held $1.31 Million

Eric Swayze Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 29 2024
BUY
Other acquisition or disposition
$20,824 $34.42 p/Share
605 Added 1.7%
34,929 Common Stock
Feb 02 2024
SELL
Open market or private sale
$94,510 $49.56 p/Share
1,907 Reduced 5.26%
34,324 Common Stock
Feb 01 2024
BUY
Grant, award, or other acquisition
-
3,715 Added 9.3%
36,231 Common Stock
Jan 31 2024
SELL
Open market or private sale
$560,196 $52.0 p/Share
10,773 Reduced 24.89%
32,516 Common Stock
Jan 17 2024
SELL
Open market or private sale
$317,444 $50.42 p/Share
6,296 Reduced 12.7%
43,289 Common Stock
Jan 16 2024
BUY
Exercise of conversion of derivative security
-
17,069 Added 25.61%
49,585 Common Stock
Dec 28 2023
SELL
Open market or private sale
$1,360,149 $50.19 p/Share
27,100 Reduced 45.46%
32,516 Common Stock
Dec 28 2023
BUY
Exercise of conversion of derivative security
$1,282,914 $47.34 p/Share
27,100 Added 31.25%
59,616 Common Stock
Feb 28 2023
BUY
Other acquisition or disposition
$17,549 $30.52 p/Share
575 Added 1.74%
32,516 Common Stock
Feb 06 2023
SELL
Open market or private sale
$74,033 $40.79 p/Share
1,815 Reduced 5.38%
31,941 Common Stock
Feb 03 2023
BUY
Grant, award, or other acquisition
-
3,715 Added 9.91%
33,756 Common Stock
Jan 18 2023
SELL
Open market or private sale
$223,775 $39.74 p/Share
5,631 Reduced 15.79%
30,041 Common Stock
Jan 17 2023
BUY
Exercise of conversion of derivative security
-
15,780 Added 30.67%
35,672 Common Stock
Sep 08 2022
SELL
Open market or private sale
$20,493 $44.55 p/Share
460 Reduced 2.26%
19,892 Common Stock
Aug 05 2022
SELL
Open market or private sale
$45 $45.2 p/Share
1 Reduced 0.0%
20,352 Common Stock
Apr 21 2022
SELL
Open market or private sale
$16,689 $44.15 p/Share
378 Reduced 1.82%
20,353 Common Stock
Feb 28 2022
BUY
Other acquisition or disposition
$17,618 $28.37 p/Share
621 Added 2.91%
20,731 Common Stock
Jan 18 2022
SELL
Payment of exercise price or tax liability
$150,419 $30.12 p/Share
4,994 Reduced 19.89%
20,110 Common Stock
Jan 18 2022
BUY
Exercise of conversion of derivative security
-
13,809 Added 35.49%
25,104 Common Stock
Feb 26 2021
BUY
Other acquisition or disposition
$20,488 $44.54 p/Share
460 Added 3.91%
11,295 Common Stock
Jan 15 2021
SELL
Payment of exercise price or tax liability
$197,076 $61.28 p/Share
3,216 Reduced 22.89%
10,835 Common Stock
Jan 15 2021
BUY
Exercise of conversion of derivative security
-
8,944 Added 38.9%
14,051 Common Stock
Jan 05 2021
SELL
Open market or private sale
$10,918 $55.99 p/Share
195 Reduced 3.68%
5,107 Common Stock
ES

Eric Swayze

Officer Level 14
Carlsbad, CA

Track Institutional and Insider Activities on IONS

Follow IONIS PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IONS shares.

Notify only if

Insider Trading

Get notified when an Ionis Pharmaceuticals Inc insider buys or sells IONS shares.

Notify only if

News

Receive news related to IONIS PHARMACEUTICALS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IONS